Literature DB >> 18845544

X11 proteins regulate the translocation of amyloid beta-protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by beta-site-cleaving enzyme in brain.

Yuhki Saito1, Yoshitake Sano, Robert Vassar, Sam Gandy, Tadashi Nakaya, Tohru Yamamoto, Toshiharu Suzuki.   

Abstract

X11 and X11-like proteins (X11L) are neuronal adaptor proteins whose association to the cytoplasmic domain of amyloid beta-protein precursor (APP) suppresses the generation of amyloid beta-protein (Abeta) implicated in Alzheimer disease pathogenesis. The amyloidogenic, but not amyloidolytic, metabolism of APP was selectively increased in the brain of mutant mice lacking X11L (Sano, Y., Syuzo-Takabatake, A., Nakaya, T., Saito, Y., Tomita, S., Itohara, S., and Suzuki, T. (2006) J. Biol. Chem. 281, 37853-37860). To reveal the actual role of X11 proteins (X11s) in suppressing amyloidogenic cleavage of APP in vivo, we generated X11 and X11L double knock-out mice and analyzed the metabolism of APP. The mutant mice showed enhanced beta-site cleavage of APP along with increased accumulation of Abeta in brain and increased colocalization of APP with beta-site APP-cleaving enzyme (BACE). In the brains of mice deficient in both X11 and X11L, the apparent relative subcellular distributions of both mature APP and its beta-C-terminal fragment were shifted toward the detergent-resistant membrane (DRM) fraction, an organelle in which BACE is active and both X11s are not nearly found. These results indicate that X11s associate primarily with APP molecules that are outside of DRM, that the dissociation of APP-X11/X11L complexes leads to entry of APP into DRM, and that cleavage of uncomplexed APP by BACE within DRM is enhanced by X11s deficiency. Present results lead to an idea that the dysfunction of X11L in the interaction with APP may recruit more APP into DRM and increase the generation of Abeta even if BACE activity did not increase in brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845544      PMCID: PMC2602917          DOI: 10.1074/jbc.M801353200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  A role for Mints in transmitter release: Mint 1 knockout mice exhibit impaired GABAergic synaptic transmission.

Authors:  Angela Ho; Wade Morishita; Robert E Hammer; Robert C Malenka; Thomas C Sudhof
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

2.  Mutant presenilin 2 transgenic mice. A large increase in the levels of Abeta 42 is presumably associated with the low density membrane domain that contains decreased levels of glycerophospholipids and sphingomyelin.

Authors:  N Sawamura; M Morishima-Kawashima; H Waki; K Kobayashi; T Kuramochi; M P Frosch; K Ding; M Ito; T W Kim; R E Tanzi; F Oyama; T Tabira; S Ando; Y Ihara
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

3.  Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression.

Authors:  Kangning Liu; Robert W Doms; Virginia M-Y Lee
Journal:  Biochemistry       Date:  2002-03-05       Impact factor: 3.162

4.  The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport.

Authors:  Yoichi Araki; Takanori Kawano; Hidenori Taru; Yuhki Saito; Sachiyo Wada; Kanako Miyamoto; Hisako Kobayashi; Hiroyuki O Ishikawa; Yu Ohsugi; Tohru Yamamoto; Kenji Matsuno; Masataka Kinjo; Toshiharu Suzuki
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

5.  Alteration of methamphetamine-induced striatal dopamine release in mint-1 knockout mice.

Authors:  Atsushi Mori; Keiji Okuyama; Masato Horie; Yoshihiro Taniguchi; Takashi Wadatsu; Naoki Nishino; Yoshikazu Shimada; Norihiro Miyazawa; Satoshi Takeda; Masashi Niimi; Hiroyuki Kyushiki; Mari Kondo; Yasuhide Mitsumoto
Journal:  Neurosci Res       Date:  2002-07       Impact factor: 3.304

6.  Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein.

Authors:  Joanna M Cordy; Ishrut Hussain; Colin Dingwall; Nigel M Hooper; Anthony J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

7.  Gamma-secretase activity is present in rafts but is not cholesterol-dependent.

Authors:  Satoko Wada; Maho Morishima-Kawashima; Yue Qi; Hiroaki Misono; Yukiko Shimada; Yoshiko Ohno-Iwashita; Yasuo Ihara
Journal:  Biochemistry       Date:  2003-12-02       Impact factor: 3.162

8.  The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice.

Authors:  Ju-Hyun Lee; Kwok-Fai Lau; Michael S Perkinton; Claire L Standen; Stephen J A Shemilt; Luc Mercken; Jonathan D Cooper; Declan M McLoughlin; Christopher C J Miller
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

9.  Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis.

Authors:  Luigi Puglielli; Blake C Ellis; Aleister J Saunders; Dora M Kovacs
Journal:  J Biol Chem       Date:  2003-03-20       Impact factor: 5.486

10.  Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts.

Authors:  Robert Ehehalt; Patrick Keller; Christian Haass; Christoph Thiele; Kai Simons
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

View more
  33 in total

Review 1.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

2.  Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance.

Authors:  Mitsuru Shinohara; Naoyuki Sato; Hitomi Kurinami; Daisuke Takeuchi; Shuko Takeda; Munehisa Shimamura; Toshihide Yamashita; Yasuo Uchiyama; Hiromi Rakugi; Ryuichi Morishita
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

3.  X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice.

Authors:  Inderjeet Saluja; Henry Paulson; Ashwin Gupta; R Scott Turner
Journal:  Neurobiol Dis       Date:  2009-07-23       Impact factor: 5.996

4.  X11/Mint genes control polarized localization of axonal membrane proteins in vivo.

Authors:  Garrett G Gross; G Mohiddin Lone; Lok Kwan Leung; Volker Hartenstein; Ming Guo
Journal:  J Neurosci       Date:  2013-05-08       Impact factor: 6.167

5.  Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction.

Authors:  Saori Hata; Sayaka Fujishige; Yoichi Araki; Miyako Taniguchi; Katsuya Urakami; Elaine Peskind; Hiroyasu Akatsu; Masahiko Araseki; Kazuo Yamamoto; Ralph N Martins; Masahiro Maeda; Masaki Nishimura; Allan Levey; Kathryn A Chung; Thomas Montine; James Leverenz; Anne Fagan; Alison Goate; Randall Bateman; David M Holtzman; Tohru Yamamoto; Tadashi Nakaya; Sam Gandy; Toshiharu Suzuki
Journal:  Ann Neurol       Date:  2011-06       Impact factor: 10.422

6.  Deletions flanked by breakpoints 3 and 4 on 15q13 may contribute to abnormal phenotypes.

Authors:  Jill A Rosenfeld; Lindsey E Stephens; Justine Coppinger; Blake C Ballif; Joe J Hoo; Beatrice N French; Valerie C Banks; Wendy E Smith; David Manchester; Anne Chun-Hui Tsai; Katrina Merrion; Roberto Mendoza-Londono; Lucie Dupuis; Roger Schultz; Beth Torchia; Trilochan Sahoo; Bassem Bejjani; David D Weaver; Lisa G Shaffer
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

7.  Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35.

Authors:  Dennis Dik-Long Chau; Kristen Wing-Yu Yung; William Wai-Lun Chan; Ying An; Yan Hao; Ho-Yin Edwin Chan; Jacky Chi-Ki Ngo; Kwok-Fai Lau
Journal:  FASEB J       Date:  2019-08-05       Impact factor: 5.191

8.  Novel mediators of amyloid precursor protein signaling.

Authors:  Andrzej Swistowski; Qiang Zhang; Mark E Orcholski; Danielle Crippen; Cathy Vitelli; Alexei Kurakin; Dale E Bredesen
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

9.  Amyloidogenic processing of amyloid β protein precursor (APP) is enhanced in the brains of alcadein α-deficient mice.

Authors:  Naoya Gotoh; Yuhki Saito; Saori Hata; Haruka Saito; Daiki Ojima; Chiaki Murayama; Mayo Shigeta; Takaya Abe; Daijiro Konno; Fumio Matsuzaki; Toshiharu Suzuki; Tohru Yamamoto
Journal:  J Biol Chem       Date:  2020-05-27       Impact factor: 5.157

10.  Increased amyloidogenic processing of transgenic human APP in X11-like deficient mouse brain.

Authors:  Maho Kondo; Maki Shiono; Genzo Itoh; Norio Takei; Takahide Matsushima; Masahiro Maeda; Hidenori Taru; Saori Hata; Tohru Yamamoto; Yuhki Saito; Toshiharu Suzuki
Journal:  Mol Neurodegener       Date:  2010-09-15       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.